Bulletin of the World Health Organization

The economic and social benefits of childhood vaccinations in BRICS

Andrew J Mirelman, Sachiko Ozawa & Simrun Grewal

Volume 92, Number 6, June 2014, 454-456

Table 2. Estimated annual economic and social benefits from increased Haemophilus influenzae type b, pneumococcal conjugate vaccine and rotavirus vaccine coverage, Brazil, the Russian Federation, India, China and South Africa (BRICS)

Country GDP per capita 2012 (US$)15 Life expectancy at birth (years)16 Estimated annual no. of averted deaths
Estimated annual economic and social benefits (US$)
Hib SP RV Total
Brazil 11 359 73.8 0 25 10 35 18 162 707
Russian Federation 14 302 67.9 373 474 31 878 559 713 873
India 1 501 66.3 52 709 54 499 29 612 136 820 9 083 890 821
China 6 071 75.2 9 538 10 079 1 170 20 787 5 796 798 644
South Africa 7 525 57.1 856 319 85 1 260 398 019 961

GDP: gross domestic product; Hib: Haemophilus influenzae type b; RV: rotavirus; SP: Streptococcus pneumonia; US$: United States dollars.